CNTNAP2 (Contactin Associated Protein 2): A Key Player in Neurodevelopmental Disorders

Explore the genomic landscape, expression, and clinical significance of CNTNAP2, a gene implicated in autism, epilepsy, and language disorders.

Gene Information Card

Symbol CNTNAP2
Full Name Contactin Associated Protein 2
Gene Type Protein coding
Chromosomal Location 7q35-q36.1
NCBI Gene ID 26047 ncbi.nlm.nih.gov/gene/26047
Ensembl ID ENSG00000174469
UniProt ID Q9UHC6
OMIM ID 604569
HGNC ID 13830
Aliases CASPR2, NRXN4, DKFZp781D1846

Description

CNTNAP2 encodes contactin-associated protein 2 (CASPR2), a member of the neurexin family of cell adhesion molecules. It is predominantly expressed in the nervous system, where it plays a critical role in neuronal-glial interactions, clustering of voltage-gated potassium channels at the juxtaparanodal regions of myelinated axons, and in the development of neural circuits. Mutations and variants in CNTNAP2 have been associated with a spectrum of neurodevelopmental disorders, including autism spectrum disorder (ASD), intellectual disability, epilepsy, and specific language impairment. The gene is also implicated in cortical development and synaptic function, making it a key candidate for understanding the molecular basis of these conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autism Spectrum Disorder Rare copy number variants and single nucleotide variants disrupt synaptic function and neuronal connectivity. ClinVar, OMIM
Epilepsy (focal and generalized) Loss-of-function mutations impair potassium channel clustering, leading to neuronal hyperexcitability. ClinVar, OMIM
Specific Language Impairment Common variants in intronic regions affect gene expression and neuronal migration. OMIM, PubMed
Intellectual Disability Homozygous and compound heterozygous mutations cause severe neurodevelopmental phenotypes. OMIM, ClinVar
Schizophrenia Association studies link CNTNAP2 variants to increased risk, possibly via altered synaptic pruning. OMIM, PubMed
Tourette Syndrome Rare variants may contribute to tic disorders through dopaminergic pathway modulation. OMIM, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebral cortex) High (nTPM ~ 30) Highest expression in cortical regions, especially in layers II-V.
Cerebellum Moderate (nTPM ~ 15) Expressed in Purkinje cells and granule cells.
Spinal cord Low (nTPM ~ 5) Present in motor neurons and interneurons.
Heart Low (nTPM ~ 2) Minimal expression, not functionally significant.
Liver Not detected No significant expression.
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) High Neuronal-like cells, used for neurodevelopmental studies.
U87 (glioblastoma) Moderate Glial cells, relevant for glial-neuronal interactions.
HEK293 (embryonic kidney) Low Used for recombinant expression studies.
HepG2 (hepatocellular carcinoma) Not detected No endogenous expression.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.3700delG (frameshift) Frameshift deletion Rare Loss of function, associated with epilepsy and intellectual disability.
p.R1117X (nonsense) Nonsense Rare Premature truncation, loss of function, linked to autism.
p.T1275M (missense) Missense Rare Altered protein stability, possibly dominant-negative effect.
Intronic variant rs7794745 SNV Common (minor allele frequency ~0.3) Associated with language impairment, affects splicing.
Copy number loss (exon 1-3) CNV Rare Haploinsufficiency, causes Pitt-Hopkins-like phenotype.
Mutation functional classification

Loss of Function (LOF)

Most pathogenic mutations are loss-of-function, leading to reduced CASPR2 protein levels or disrupted interactions with contactin and potassium channels, impairing neuronal signaling.

Gain of Function (GOF)

No clear gain-of-function mutations have been reported; the gene primarily acts as a tumor suppressor in neurodevelopment, and gain-of-function is not a recognized mechanism.

Dominant Negative (DN)

Some missense mutations may exert dominant-negative effects by forming non-functional complexes with wild-type CASPR2, disrupting normal protein function.

Gene Ontology (GO)

• cell adhesion • protein binding
• voltage-gated potassium channel complex • axon guidance
• synaptic transmission • nervous system development
• myelination • neuron projection

Pathways

Neurexin and neuroligin signaling
Potassium channel clustering
Axon guidance and neuronal migration
Synaptic vesicle cycle

Protein Summary

CASPR2 is a single-pass type I membrane protein with a large extracellular domain containing multiple laminin G, EGF-like, and fibronectin type III domains. It interacts with contactin-2 (CNTN2) to mediate cell adhesion and is essential for the localization of voltage-gated potassium channels (Kv1.1/Kv1.2) at the juxtaparanodal region of myelinated axons. CASPR2 also plays roles in neuronal migration, dendritic arborization, and synaptic plasticity. Its cytoplasmic domain interacts with PDZ-domain proteins, linking it to intracellular signaling pathways. Mutations affecting CASPR2 function lead to altered neuronal excitability and connectivity, underpinning various neurodevelopmental disorders.

Related Products

Product name Cat.No. Species Gene ID
CNTNAP2 Knockout HEK293 Cell Line EDJ-KQ8366 Human 26047 Details Get a Quote
CNTNAP2 Knockout HeLa Cell Line EDJ-KQ55874 Human 26047 Details Get a Quote
CNTNAP2 Knockout A-549 Cell Line EDJ-KQ64364 Human 26047 Details Get a Quote
CNTNAP2 Knockout HCT 116 Cell Line EDJ-KQ72814 Human 26047 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: